Nomic (formerly nplex biosciences) is a bioengineering company working to make the human proteome as broadly and easily accessible as the human genome. We are building the nELISA, a next-generation ELISA platform for measuring proteins at scale and at high throughput. The nELISA was designed to seamlessly integrate into current workflows in biology and is uniquely adaptable to a wide variety of use cases within drug and biomarker development workflows. Nomic is headquartered in Montreal, with labs and offices in Boston. For more information, visit www.nomic.bio.
Employees: 11-50
Total raised: $59M
Founded date: 2017
Investors 6
| Date | Name | Website |
| 31.01.2022 | Y Combinat... | ycombinato... |
| - | Transolam | transolam.... |
| 22.12.2021 | Lux Capita... | luxcapital... |
| - | Real Ventu... | realventur... |
| 04.05.2022 | First Star... | firststar.... |
| 16.12.2021 | SR One | srone.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 18.09.2024 | Series B | $42M | - |
| 08.12.2021 | Series A | $17M | - |
Mentions in press and media 6
| Date | Title | Description |
| 19.09.2024 | Nomic Bio's $42 Million Leap: A New Era in Protein Profiling | Nomic Bio has just made waves in the life sciences sector. The Montréal-based protein profiling company secured $42 million in Series B funding. This financial boost is not just a number; it’s a ticket to innovation. With this capital, Nomi... |
| 18.09.2024 | Nomic Bio: Protein Profiling Company Raises $42 Million (Series B) | Protein Profiling company Nomic Bio announced it raised $42 million in Series B funding. This funding round will enable Nomic to accelerate the expansion of its commercial operations, further invest in advancing its state-of-the-art protein... |
| 17.09.2024 | Nomic Raises $42M in Series B Funding | Nomic Bio, a Montréal, Canada-based protein profiling company, raised $42M in Series B funding. The round was led by an undisclosed life-sciences-focused investor with participation from new and existing investors, including Amplitude Ventu... |
| 09.12.2021 | Nomic Bio Raises $17M in Series A Funding | Nomic Bio (formerly nplex biosciences), a Montreal, Canada-based protein profiling company, raised $17M in Series A funding. The round, which brought total funding raised to date to over US$21m, was led by Lux Capital, joined by SR One and ... |
| 08.12.2021 | Rebranded Nomic Bio raises $17 million to fuel development of protein-measuring platform | Nomic Bio has secured a new name and $17 million USD in Series A financing to support the growth of its protein-measuring platform. Nomic hopes to “revolutionize” how drugs are developed and diseases are diagnosed and treated. Founded in 20... |
| - | Nomic | “Learn how Nomic's nELISA™ enables high-fidelity multiplexing, à-la-carte protein selection, and unmatched cost-efficiency. All using a white-glove service with end-to-end support and a 1 week turnaround.” |